Octreotide in the treatment of neuroendocrine carcinomas: Is the success achieved?
Diagnosis and treatment of functioning and non-functioning neuroendocrine tumors is a challenging task. Surgeru remains the only radical method of treatment of these tumors, but tumors often are diagnosed at the stage of metastasis, when only palliative treatment is possible. Octreotide in patients...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
QUASAR, LLC
2015-06-01
|
| Series: | Исследования и практика в медицине |
| Subjects: | |
| Online Access: | https://www.rpmj.ru/rpmj/article/view/64 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841524392963604480 |
|---|---|
| author | L. Yu. Morgunov |
| author_facet | L. Yu. Morgunov |
| author_sort | L. Yu. Morgunov |
| collection | DOAJ |
| description | Diagnosis and treatment of functioning and non-functioning neuroendocrine tumors is a challenging task. Surgeru remains the only radical method of treatment of these tumors, but tumors often are diagnosed at the stage of metastasis, when only palliative treatment is possible. Octreotide in patients with neuroendocrine tumors remains a drug with proven efficacy that can suppress the clinical symptoms of carcinoid syndrome and has antiproliferative activity, which can improve the quality of life and prolong survival. |
| format | Article |
| id | doaj-art-e8f9d37a025f48838c97bad9c53ce55b |
| institution | Kabale University |
| issn | 2410-1893 |
| language | Russian |
| publishDate | 2015-06-01 |
| publisher | QUASAR, LLC |
| record_format | Article |
| series | Исследования и практика в медицине |
| spelling | doaj-art-e8f9d37a025f48838c97bad9c53ce55b2025-02-03T07:12:18ZrusQUASAR, LLCИсследования и практика в медицине2410-18932015-06-0122637210.17709/2409-2231-2015-2-2-63-7243Octreotide in the treatment of neuroendocrine carcinomas: Is the success achieved?L. Yu. Morgunov0Moscow State University of Medicine and Dentistry named after A.I. Evdokimov Ulitsa Delegatskaya, 20/1, Moskva, 127473, RussiaDiagnosis and treatment of functioning and non-functioning neuroendocrine tumors is a challenging task. Surgeru remains the only radical method of treatment of these tumors, but tumors often are diagnosed at the stage of metastasis, when only palliative treatment is possible. Octreotide in patients with neuroendocrine tumors remains a drug with proven efficacy that can suppress the clinical symptoms of carcinoid syndrome and has antiproliferative activity, which can improve the quality of life and prolong survival.https://www.rpmj.ru/rpmj/article/view/64octreotide, somatostatin analogues, neuroendocrine carcinomas, carinoid syndrome |
| spellingShingle | L. Yu. Morgunov Octreotide in the treatment of neuroendocrine carcinomas: Is the success achieved? Исследования и практика в медицине octreotide, somatostatin analogues, neuroendocrine carcinomas, carinoid syndrome |
| title | Octreotide in the treatment of neuroendocrine carcinomas: Is the success achieved? |
| title_full | Octreotide in the treatment of neuroendocrine carcinomas: Is the success achieved? |
| title_fullStr | Octreotide in the treatment of neuroendocrine carcinomas: Is the success achieved? |
| title_full_unstemmed | Octreotide in the treatment of neuroendocrine carcinomas: Is the success achieved? |
| title_short | Octreotide in the treatment of neuroendocrine carcinomas: Is the success achieved? |
| title_sort | octreotide in the treatment of neuroendocrine carcinomas is the success achieved |
| topic | octreotide, somatostatin analogues, neuroendocrine carcinomas, carinoid syndrome |
| url | https://www.rpmj.ru/rpmj/article/view/64 |
| work_keys_str_mv | AT lyumorgunov octreotideinthetreatmentofneuroendocrinecarcinomasisthesuccessachieved |